4.7 Review

Are Cerebrospinal Fluid Biomarkers Useful in Predicting the Prognosis of Multiple Sclerosis Patients?

Journal

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 12, Issue 11, Pages 7960-7970

Publisher

MDPI
DOI: 10.3390/ijms12117960

Keywords

multiple sclerosis; biomarkers; cystatin C; 14-3-3 protein; tau protein

Funding

  1. Fondazione Cariverona
  2. University of Verona

Ask authors/readers for more resources

Multiple sclerosis (MS) is the prototypical inflammatory demyelinating disorder of the central nervous system (CNS). Although many advances have been made in the comprehension of its pathogenesis, the etiology is still unknown. The complexity of MS reflects in the extreme variability of the clinical manifestations and clinical course both between and within patients, in addition to immunopathological mechanisms and response to treatment. Several prognostic factors have been suggested in large scale studies, but predictions in individual cases are difficult to make. Cerebrospinal fluid (CSF) biomarkers, such as 14-3-3, tau, and cystatin C are promising sources of prognostic information with a good potential of quantitative measure, sensitivity, and reliability. However, none has shown sufficient reproducibility to be applied in clinical practice. Here we review the current literature addressing the above mentioned biomarkers as MS severity predictors at an early stage.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

Clinical Presentation and Outcomes of Severe Acute Respiratory Syndrome Coronavirus 2-Related Encephalitis: The ENCOVID Multicenter Study

Andrea Pilotto, Stefano Masciocchi, Irene Volonghi, Massimo Crabbio, Eugenio Magni, Valeria De Giuli, Francesca Caprioli, Nicola Rifino, Maria Sessa, Michele Gennuso, Maria Sofia Cotelli, Marinella Turla, Ubaldo Balducci, Sara Mariotto, Sergio Ferrari, Alfonso Ciccone, Fabrizio Fiacco, Alberto Imarisio, Barbara Risi, Alberto Benussi, Enrico Premi, Emanuele Foca, Francesca Caccuri, Matilde Leonardi, Roberto Gasparotti, Francesco Castelli, Gianluigi Zanusso, Alessandro Pezzini, Alessandro Padovani

Summary: SARS-CoV-2 infection is associated with a wide spectrum of encephalitis characterized by different clinical presentations, response to treatment, and outcomes. The study identified subtypes of encephalitis based on MRI results, with patients showing acute demyelinating encephalomyelitis and limbic encephalitis having a delayed onset and more severe COVID-19 respiratory involvement. Patients with MRI alterations exhibited worse response to treatment and final outcomes.

JOURNAL OF INFECTIOUS DISEASES (2021)

Letter Clinical Neurology

COVID-19 impact on consecutive neurological patients admitted to the emergency department

Andrea Pilotto, Alberto Benussi, Ilenia Libri, Stefano Masciocchi, Loris Poli, Enrico Premi, Antonella Alberici, Enrico Baldelli, Sonia Bonacina, Laura Brambilla, Matteo Benini, Salvatore Caratozzolo, Matteo Cortinovis, Angelo Costa, Stefano Cotti Piccinelli, Elisabetta Cottini, Viviana Cristillo, Ilenia Delrio, Massimiliano Filosto, Massimo Gamba, Stefano Gazzina, Nicola Gilberti, Stefano Gipponi, Marcello Giunta, Alberto Imarisio, Paolo Liberini, Martina Locatelli, Francesca Schiano, Ranata Rao, Barbara Risi, Luca Rozzini, Andrea Scalvini, Veronica Vergani, Irene Volonghi, Nicola Zoppi, Barbara Borroni, Mauro Magoni, Matilde Leonardi, Gianluigi Zanusso, Sergio Ferrari, Sara Mariotto, Alessandro Pezzini, Roberto Gasparotti, Ciro Paolillo, Alessandro Padovani

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)

Article Immunology

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Encephalitis Is a Cytokine Release Syndrome: Evidences From Cerebrospinal Fluid Analyses

Andrea Pilotto, Stefano Masciocchi, Irene Volonghi, Valeria De Giuli, Francesca Caprioli, Sara Mariotto, Sergio Ferrari, Silvia Bozzetti, Alberto Imarisio, Barbara Risi, Enrico Premi, Alberto Benussi, Emanuele Foca, Francesco Castelli, Gianluigi Zanusso, Salvatore Monaco, Paola Stefanelli, Roberto Gasparotti, Anastasia Zekeridou, Andrew McKeon, Nicholas J. Ashton, Kaj BlennoW, Henrik Zetterberg, Alessandro Padovani

Summary: SARS-CoV-2-related encephalitis is associated with prominent glial activation and neuroinflammatory markers, with neuronal markers increased only in severe cases. The pattern of CSF alterations suggests cytokine-release syndrome as the main inflammatory mechanism of SARS-CoV-2-related encephalitis.

CLINICAL INFECTIOUS DISEASES (2021)

Article Clinical Neurology

Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study

Maria Di Gregorio, Valentina Liliana Adriana Torri Clerici, Giuseppe Fenu, Lorenzo Gaetani, Antonio Gallo, Paola Cavalla, Paolo Ragonese, Pietro Annovazzi, Alberto Gajofatto, Luca Prosperini, Doriana Landi, Carolina Gabri Nicoletti, Caterina Di Carmine, Rocco Totaro, Viviana Nociti, Chiara De Fino, Diana Ferraro, Valentina Tomassini, Carla Tortorella, Isabella Righini, Maria Pia Amato, Alessia Manni, Damiano Paolicelli, Pietro Iaffaldano, Roberta Lanzillo, Marcello Moccia, Fabio Buttari, Roberta Fantozzi, Raffaella Cerqua, Sara Zagaglia, Deborah Farina, Giovanna De Luca, Maria Chiara Buscarinu, Federica Pinardi, Eleonora Cocco, Claudio Gasperini, Claudio Marcello Solaro, Massimiliano Di Filippo

Summary: The study found that tumefactive multiple sclerosis (TuMS) primarily affects women with a young onset age, and presents with unique disease characteristics. Some patients require multiple acute-phase treatments, while those with certain risk factors may experience disease progression.

EUROPEAN JOURNAL OF NEUROLOGY (2021)

Review Neurosciences

Hypothalamic-Bulbar MRI Hyperintensity in Anti-IgLON5 Disease with Serum-Restricted Antibodies: A Case Report and Systematic Review of Literature

Matteo Tagliapietra, Emma Frasson, Davide Cardellini, Sara Mariotto, Sergio Ferrari, Gianluigi Zanusso, Mauro Plebani, Salvatore Monaco

Summary: Anti-IgLON5 disease is a rare neurodegenerative tauopathy with varied clinical spectrum, presenting symptoms including sleep disorders, bulbar dysfunction, and gait abnormalities. While conventional brain MRI may be unrevealing, CSF findings and immunotherapy responses can be helpful in diagnosis and treatment for some patients.

JOURNAL OF ALZHEIMERS DISEASE (2021)

Review Clinical Neurology

Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease

Peter Hermann, Brian Appleby, Jean-Philippe Brandel, Byron Caughey, Steven Collins, Michael D. Geschwind, Alison Green, Stephane Haik, Gabor G. Kovacs, Anna Ladogana, Franc Llorens, Simon Mead, Noriyuki Nishida, Suvankar Pal, Piero Parchi, Maurizio Pocchiari, Katsuya Satoh, Gianluigi Zanusso, Inga Zerr

Summary: Sporadic Creutzfeldt-Jakob disease is a fatal neurodegenerative disease caused by misfolded prion proteins. Its diagnosis relies on a combination of neuropsychiatric symptoms, CSF markers, and imaging. The development of assays like RT-QuIC has improved diagnostic accuracy.

LANCET NEUROLOGY (2021)

Article Clinical Neurology

RFC1 AAGGG repeat expansion masquerading as Chronic Idiopathic Axonal Polyneuropathy

Matteo Tagliapietra, Davide Cardellini, Moreno Ferrarini, Silvia Testi, Sergio Ferrari, Salvatore Monaco, Tiziana Cavallaro, Gian Maria Fabrizi

Summary: The study highlights the frequent occurrence of the RFC1 AAGGG repeat expansion in patients diagnosed with CIAP and characterizes the clinical and pathological features associated with this neuro(no)pathy. The mutation is associated with sensory ataxia, autonomic disturbances, and retained deep tendon reflexes.

JOURNAL OF NEUROLOGY (2021)

Letter Clinical Neurology

NfL levels predominantly increase at disease onset in MOG-Abs-associated disorders

Sara Mariotto, Matteo Gastaldi, Luisa Grazian, Chiara Mancinelli, Ruggero Capra, Romain Marignier, Daniela Alberti, Serena Zanzoni, Kathrin Schanda, Diego Franciotta, Francesca Calabria, Salvatore Monaco, Markus Reindl, Sergio Ferrari, Alberto Gajofatto

Summary: In patients with MOGAD, levels of neurofilament light chain (NfL) indicate that the primary axonal damage occurs at disease onset, which may be the main driver of long-term disability. Follow-up measurements showed stable or decreased NfL levels, providing important insights into the progression of the disease and potential treatment implications.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)

Meeting Abstract Clinical Neurology

Encephalitis during first year of SARS-COV-2 pandemic-first results of the European ENCOVID registry

Andrea Pilotto, Stefano Masciocchi, Elisabetta Del Zotto, Irene Volonghi, Eugenio Magni, Valeria De Giuli, Bruno Censori, Nicola Rifino, Maria Sessa, Michele Gennuso, Sara Mariotto, Sergio Ferrari, Lucia Tesolin, Franco Teatini, Maria Sofia Cotelli, Marinella Turla, Ubaldo Balducci, Raphael Bernard-Valnet, Alfonso Ciccone, Fabrizio Fiacco, Alberto Imarisio, Barbara Risi, Emanuele Foca, Arnaldo Caruso, Matilde Leonardi, Roberto Gasparotti, Francesco Castelli, Gianluigi Zanusso, Alberto Romagnolo, Leonardo Lopiano, Piergiorgio Lochner, Klaus Fassbender, Alessandro Padovani

JOURNAL OF THE NEUROLOGICAL SCIENCES (2021)

Meeting Abstract Clinical Neurology

Cortical basal syndrome in a patient with a clinical and pathological overlap between Tauopathy and Synucleinopathy. Evidence from the Tredem registry

Maurizio Gallucci, Anna Paola Mazzarolo, Vittorio Fiore, Matteo Bendini, Gianluigi Zanusso, Laura Bonanni

JOURNAL OF THE NEUROLOGICAL SCIENCES (2021)

Article Clinical Neurology

Persistent chemosensory dysfunction in a young patient with mild COVID-19 with partial recovery 15 months after the onset

Maria Paola Cecchini, Lorenzo Brozzetti, Nicolo Cardobi, Luca Sacchetto, Davide Gibellini, Stefania Montemezzi, Marta Cheli, Paolo Manganotti, Salvatore Monaco, Gianluigi Zanusso

Summary: A 17-year-old female patient experienced long-lasting anosmia after a mild infection, with partial recovery 15 months later. Neuroimaging did not show microvascular injury in olfactory bulbs and brain, and the patient exhibited symptoms of anosmia with parosmia phenomena and gustatory impairment. Immunocytochemistry of olfactory mucosa swabs revealed high expression of ACE2 in sustentacular cells and lower expression in neuronal-shaped cells. Further longitudinal studies are needed to investigate the persistence of chemosensory impairment.

NEUROLOGICAL SCIENCES (2022)

Article Clinical Neurology

Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity

Alberto Gajofatto, Nicolo Cardobi, Francesca Gobbin, Massimiliano Calabrese, Marco Turatti, Maria Donata Benedetti

Summary: This study used resting state functional magnetic resonance imaging (fMRI) to investigate changes in brain network connectivity in multiple sclerosis (MS) patients treated with Sativex (R). The results showed that Sativex (R) treatment was associated with an increase in brain connectivity in MS patients, particularly in responders.

BMC NEUROLOGY (2023)

Article Food Science & Technology

Algal blooms of Alexandrium spp. and Paralytic Shellfish Poisoning toxicity events in mussels farmed in Sicily

Antonella Costa, Vincenzina Alio, Sonia Sciortino, Luisa Nicastro, Monica Cangini, Fiorella Pino, Irene Servadei, Angelo La Vignera, Gianluca Fortino, Salvatore Monaco, Sonia Dall'Ara

Summary: Marine biotoxins can be transferred to humans through filter-feeders bivalve molluscs, potentially causing health issues. Harmful Algal Blooms may result in economic losses for aquaculture.

ITALIAN JOURNAL OF FOOD SAFETY (2021)

Article Medicine, General & Internal

Statin-associated necrotizing autoimmune myopathy with concurrent myasthenia gravis

Emma Frasson, Marco Simonetto, Laura Bertolasi, Giorgio Caneve, Cristina Vilotti, Giampietro Ruzza, Anna Perelli, Maria Grazia Piccinno, Salvatore Monaco

Summary: The patient had previously been treated with statins and then developed necrotizing autoimmune myopathy and myasthenia gravis, posing an unprecedented clinical challenge.

CLINICAL CASE REPORTS (2021)

Article Clinical Neurology

Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies

Daniela Perra, Matilde Bongianni, Giovanni Novi, Francesco Janes, Valentina Bessi, Stefano Capaldi, Luca Sacchetto, Matteo Tagliapietra, Guido Schenone, Silvia Morbelli, Michele Fiorini, Tatiana Cattaruzza, Giulia Mazzon, Christina D. Orru, Mauro Catalan, Paola Polverino, Andrea Bernardini, Gaia Pellitteri, Mariarosa Valente, Claudio Bertolotti, Benedetta Nacmias, Giandomenico Maggiore, Tiziana Cavallaro, Paolo Manganotti, Gianluigi Gigli, Salvatore Monaco, Flavio Nobili, Gianluigi Zanusso

Summary: The study examined the diagnostic accuracy of alpha-synuclein real-time quaking-induced conversion assay in detecting alpha-synuclein in olfactory mucosa and CSF of patients with suspected dementia with Lewy bodies. The results suggest that this approach could optimize clinical diagnosis and potentially improve concordance with clinical diagnosis.

BRAIN COMMUNICATIONS (2021)

No Data Available